טוען...
miR-508-3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7
Ovarian cancer is the most lethal gynecological tumor, and the 5-year survival rate is only ~40%. The poor survival rate is due to cancer diagnosis at an advanced stage, when the tumor has metastasized. A better understanding of the molecular pathogenesis of tumor growth and metastasis is needed to...
שמור ב:
| הוצא לאור ב: | Int J Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7252466/ https://ncbi.nlm.nih.gov/pubmed/32377701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5055 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|